X
QGEN icon

Xponance’s Qiagen QGEN Stock Holding History

Xponance’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602K Sell
15,409
-82
-0.5% -$3.04K ﹤0.01% 1013
2026
Q1 		$620K Buy
15,491
+4,991
+48% +$236K ﹤0.01% 921
2025
Q4 		$472K Buy
10,500
+157
+2% +$7.26K ﹤0.01% 975
2025
Q3 		$462K Sell
10,343
-36
-0.3% -$1.72K ﹤0.01% 1004
2025
Q2 		$499K Buy
10,379
+6
+0.1% +$261 ﹤0.01% 948
2025
Q1 		$416K Buy
10,373
+100
+1% +$4.21K ﹤0.01% 989
2024
Q4 		$471K Buy
10,273
+1,248
+14% +$55.9K ﹤0.01% 964
2024
Q3 		$423K Buy
9,025
+502
+6% +$22.9K ﹤0.01% 989
2024
Q2 		$360K Sell
8,523
-700
-8% -$30.7K ﹤0.01% 1003
2024
Q1 		$408K Buy
9,223
+161
+2% +$7.34K ﹤0.01% 1004
2023
Q4 		$417K Buy
9,062
+239
+3% +$10.2K 0.01% 990
2023
Q3 		$379K Buy
8,823
+735
+9% +$34.3K 0.01% 981
2023
Q2 		$386K Buy
8,088
+621
+8% +$29.9K 0.01% 981
2023
Q1 		$364K Buy
7,467
+47
+0.6% +$2.39K 0.01% 994
2022
Q4 		$392K Buy
+7,420
New +$366K 0.01% 970

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Xponance's QGEN Position: Q2 2026 in Review

Xponance reduced its Qiagen (QGEN) stake by 0.53% in Q2 2026, selling an estimated $3.04K and leaving 15,409 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Xponance first reported a position in QGEN in Q4 2022 and has held it in 15 quarters since. The position peaked at $620K in Q1 2026. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Xponance held 15,409 shares of Qiagen worth $602K as of Q2 2026.
  • Xponance sold 82 Qiagen shares in Q2 2026, an estimated $3.04K.
  • Qiagen made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1013 holding.
  • Xponance first reported a position in Qiagen in Q4 2022 and has held it in 15 quarters since.
  • Xponance's Qiagen position peaked at $620K in Q1 2026.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.